MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease

    K. Brockmann, JC. Corvol, A. Difonzo, S. Durrleman, T. Gasser, M. Hu, R. Krüger, I. Liepelt-Scarfone, M. Matarazzo, A. Pilotto, T. Simuni, P. Svenningsson, D. Weintraub, G. Pagano (Tuebingen, Germany)

    Objective: To prevent cognitive decline in GBA-associated Parkinson’s Disease (PD). Background: Dementia represents a key milestone in the course of PD with limited effective treatments…
  • 2023 International Congress

    Pseudogout Mimicking Stiffness in Parkinson’s Disease: A Case Report

    S. Kazanci, M. Afshari, J. Fleisher (Chicago, USA)

    Objective: N/A Background: Levodopa-responsive muscular rigidity is one of the hallmarks of Parkinson’s disease (PD). Many rheumatological conditions can present with stiffness1-4. For example, polymyalgia…
  • 2023 International Congress

    Needs assessment of patients with Parkinson’s disease: a qualitative study

    N. Geraminejad, A. Darvishpoor Kakhki (Tehran, Islamic Republic of Iran)

    Objective: This research was conducted with a qualitative approach to assess the needs of patients with Parkinson's disease Background: In the health system, the provision…
  • 2023 International Congress

    Risk of Parkinson’s disease in spinal cord injury: a nationwide cohort study in south Korea

    JH. Ahn, KD. Han, H. Choi, W. Jung, JW. Cho, J. Youn, DW. Shin (Seoul, Republic of Korea)

    Objective: In the present population-based study, we investigated the association of PD with SCI according to the severity of disability and injured spinal cord level,…
  • 2023 International Congress

    Prognostic significance of peripheral neutrophils and lymphocytes in early Parkinson’s disease

    JS. Jun, R. Kim (Seoul, Republic of Korea)

    Objective: To explore whether peripheral blood neutrophils and lymphocytes are associated with longitudinal motor and cognitive decline in patients with early Parkinson’s disease (PD) and,…
  • 2023 International Congress

    Benefits of Physician-Pharmacist Collaboration on Patient Outcomes in Parkinson’s Disease and Movement Disorders Clinic

    P. Techa-Angkoon, Y. Pitakpatapee, W. Saengphatrachai, P. Srivanitchapoom, T. Suansanae (Bangkok, Thailand)

    Objective: To evaluate the impact of pharmacist participation in Parkinson’s disease and movement disorders clinic on the number of drug-related problems (DRPs), clinical outcomes, and…
  • 2023 International Congress

    Hypothalamic involvement in Multiple System Atrophy: a clinical and neuroimaging study

    J. Pasquini, M. Firbank, L. Best, V. Foster, R. Ceravolo, G. Petrides, K. Anderson, D. Brooks, N. Pavese (Pisa, Italy)

    Objective: To investigate hypothalamic atrophy and its clinical correlates in Multiple System Atrophy (MSA) through MRI. Background: MSA is characterized by autonomic dysfunction, i.e. orthostatic…
  • 2023 International Congress

    Pallidal DBS improves myoclonus in 2 patients with post-hypoxic myoclonus

    L. Pan, A. Mogilner, S. Frucht (New York, USA)

    Objective: Describe DBS for 2 patients with severe post-hypoxic myoclonus. Background: Limited prior reports have shown improvement of PHM after DBS. We describe 2 recent…
  • 2023 International Congress

    Hypnosis as an adjunctive treatment for FND, a case series

    J. Chen, J. Waugh, K. Brewer-Mixon, S. Chitnis, D. Morris (Dallas, USA)

    Objective: To review three cases of Functional Neurologic Disorder (FND) that resolved successfully with Hypnosis and to identify the specific techniques and reasons behind their…
  • 2023 International Congress

    Understanding Social Isolation before, during and after the Covid-19 pandemic among Patients with Parkinson’s disease

    A. Mehta, S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)

    Objective: The aim of this study was to understand and measure the effect of social network support in patients with Parkinson’s disease(PwP) before, during and…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24187 (not found)
  • #29526 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley